News

MSCI's Steady Performance Amid Mixed Results: Analyst Insights

MSCI's Steady Performance Amid Mixed Results: Analyst Insights

MSCI Inc. Maintains Steady Outlook Amid Financial Challenges

Goldman Sachs has affirmed its Neutral rating on MSCI Inc. (NYSE: MSCI) with a price target of $617.00, reflecting a blend of strengths and challenges in the company's recent financial performance. The analyst recognized that although MSCI surpassed consensus expectations in revenue, EBITDA margins, and earnings per share, the firm faced setbacks in net new recurring subscription sales and ongoing uncertainty in the buy-side trends.

Potential Growth Opportunities Highlighted

Despite the current challenges, MSCI demonstrated strong performance in its Index asset-based fees, bolstered by significant fund inflows into ETFs linked to its indexes, as well as a general market appreciation. The company's robust growth in new sales across its Index and Analytics divisions has also been noteworthy.

However, in the third quarter, MSCI experienced a decline in net new recurring subscription sales, which has been largely attributed to increased cancellations. Analysts expect these cancellations to remain elevated into the fourth quarter, creating a cautious outlook for subscription growth.

ESG & Climate Segment Performance

MSCI's ESG and Climate segment, while still a critical focus, showed more moderate growth than in previous periods. Asset managers have currently slowed their purchases of these solutions, presenting a mixed picture for this sector. Nevertheless, there are signs of stabilization in the market, such as leveling off in outflows from active manager assets under management (AUM), which could suggest a potential rebound in client budgets by 2025.

Impressive Third-Quarter Results

In other recent developments, MSCI Inc. released strong third-quarter earnings, with adjusted earnings per share of $3.86 surpassing the expected $3.76. Revenue increased by 15.9% on a year-over-year basis, reaching $724.7 million and exceeding estimates of $714.6 million. A significant contributor to this growth was MSCI's Index segment, which reported an operating revenue increase of 11.8%, totaling $404.9 million.

Alongside this, the asset-based fees soared by 19.5% to $168.6 million, reflecting the rise in assets under management for ETFs and other investment products tied to MSCI’s indexes. Additionally, MSCI's Analytics segment showcased impressive growth, with revenue rising 11.7% to $172.4 million, while the ESG and Climate revenue grew by 14.5% to $83.6 million.

MSCI’s Financial Health and Future Prospects

According to further analyses that align with the impressions gathered by Goldman Sachs, MSCI's financial standing is bolstered by real-time data indicating a revenue growth of 15.03% over the past year, alongside a strong gross profit margin of 82.08%. This positions MSCI strongly in the market, reinforcing the observations made regarding its performance across Index asset-based fees and broader sales divisions.

Goldman Sachs' insights also highlight the company’s impressive track record of raising dividends for 11 consecutive years, culminating in a current dividend yield of 1.11%. This commitment to dividend growth, including a recent 15.94% increase, underscores MSCI's dedication to providing shareholder returns and its financial robustness. Furthermore, the company has demonstrated a solid return over the past five years, portraying its long-term investment value.

Efficiency and Profitability in Operations

Despite facing challenges in subscription sales, MSCI operates efficiently, as evidenced by its operating income margin of 53.72%. Such efficiency is a reassuring factor for investors as analysts predict that the company will maintain profitability this fiscal year, offering some optimism amid the prevailing market uncertainties.

Frequently Asked Questions

What is MSCI's stock rating from Goldman Sachs?

Goldman Sachs maintains a Neutral rating for MSCI Inc. with a price target of $617.00.

How did MSCI perform in the recent quarter?

MSCI reported adjusted earnings per share of $3.86 and a revenue increase of 15.9%, reaching $724.7 million.

How have MSCI's ESG and Climate revenues changed?

Revenues from the ESG and Climate segment increased by 14.5%, reaching $83.6 million.

What challenges is MSCI facing currently?

MSCI faces challenges due to high cancellations resulting in a decline in net new recurring subscription sales.

What does the future hold for MSCI?

Despite near-term challenges, there are signs of stabilization in the market, suggesting potential growth improvements by 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 15

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Radiation Oncologist Dr. Pennock Honored: A Closer Look

Updated Category News Views 10

An Honor from The Inner Circle Sometimes, in a field stuffed with brilliant minds, a beacon stands out. That's Dr. Michael M. Pennock for you—a man who doesn’t just treat cancer patients but transforms their journeys with precision and empathy. Recognized as a Pinnacle Lifetime Member by The Inner Circle, Pennock’s dedication in the field of radiation oncology is...

Continue Reading
Infection Control Market Set for Explosive Growth by 2031

Updated Category News Views 35

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Continue Reading
CashNetUSA Faces Class Action Over Exploitative Rates

Updated Category News Views 0

High-Risk Lending Meets Military Protections Ever seen a seemingly legal scheme that just leaves a sour taste? That's the vibe with CashNetUSA right now. They've landed in the hot seat over allegedly sky-high interest rates served up to folks who put on a uniform. We're talking about a proposed nationwide class action lawsuit accusing the lender of giving active-duty...

Continue Reading
Danobatgroup's New HQ in Shanghai Marks Strategic Shift

Updated Category News Views 83

Shanghai Beckons: A Game Changer for Danobatgroup One crisp morning in Shanghai marks a turning point for Danobatgroup. The Spanish heavy-hitter in machine tools has pinpointed the Shanghai Xinzhuang Industry Park in Minhang District for its Asia-Pacific headquarters. It ain't just another blip on the radar—this one's a calculated leap. Location, Location, Location...

Continue Reading
FluxCap Launches: Empowering Lawyers with Dynamic Tech

Updated Category News Views 54

A Fresh Force in Legal Tech: FluxCap Debuts Alright, strap in because the legal world just got itself a new team in the majors. FluxCap is breaking out into the open, promising to shake up how big, gnarly cases get tackled. These aren't just any cases; we're talking the kind that keep antitrust knuckles white and palms sweaty. It's like watching seasoned racecar drivers...

Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member

Updated Category News Views 84

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 53

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Sony's LYTIA 720 Image Sensor: A Game Changer?

Updated Category News Views 88

Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...

Continue Reading
Civitas Boosts Orlando Luxury Hotel with $386M Loan

Updated Category News Views 0

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Continue Reading

Top 5 Most Recently Viewed Articles

Orbit Garant's First Quarter 2026 Performance Reviewed

Updated Category News Views 157

Overview of Financial Performance Orbit Garant Drilling Inc. (TSX: OGD) has released its financial results for the first quarter of fiscal 2026, ending on September 30, 2025. During this three-month period, the company recorded a revenue of $46.7 million, marking a 3.7% decline compared to $48.4 million during the same period last year. The revenue figures reflect a range...

Continue Reading
Celebrating Leadership Excellence at Coldwell Banker 2025

Updated Category News Views 250

Celebrating Achievements in Real Estate Leadership The Leadership Awards highlight the dedication of Coldwell Banker-affiliated real estate professionals who embody the core values of the organization. Recognizing Outstanding Contributions With a strong commitment to innovation and community service, Coldwell Banker Real Estate LLC, a subsidiary of Anywhere Real Estate...

Continue Reading
U.S. Drone Production Boost Promises Growth for Key Companies

Updated Category News Views 167

Major Shift in U.S. Drone Production Policies The recent announcement from the U.S. Defense Secretary has ignited excitement in the drone manufacturing industry. On a significant day, the Secretary unveiled plans to fast-track drone production through reforms aimed at simplifying procurement processes within the Pentagon. This bold move signifies a departure from previous...

Continue Reading
Acacia Research Set for Q3 2024 Financial Results Release

Updated Category News Views 96

Exciting Announcement from Acacia Research Acacia Research Corporation (NASDAQ: ACTG) is poised to share its financial outcomes for the third quarter of 2024. This revelation is set to occur before the market opens on a significant day in November. Businesses and investors alike are eager to gain insights into the company’s latest financial endeavors. What to Expect...

Continue Reading
Revolutionizing Grocery Shopping: Deliverect's New Retail Solution

Updated Category News Views 185

Revolutionizing Grocery Retail with Deliverect's Innovative Solution Deliverect, a leader in food technology software as a service (SaaS), has introduced Deliverect Retail to enhance the digital shopping experience for groceries. This important development allows grocery retailers to operate more effectively, which leads to better sales and improves customer satisfaction....

Continue Reading